Conference Coverage

Vascular disease linked to sight loss in giant cell arteritis

Publish date: May 10, 2016

 

AT RHEUMATOLOGY 2016

References

The DCVAS study is supported by the ACR and is funded by the European League Against Rheumatism and the Vasculitis Foundation. Dr. Yates reported that he had no relevant disclosures.

Pages

Recommended Reading

Home infusion policies called out in ACR position statement
MDedge Rheumatology
Pushback on Part B drug payment proposal already beginning
MDedge Rheumatology
Lupus patients’ transition to adult care leaves gaps, delays in care
MDedge Rheumatology
Cutaneous lupus may raise risk of stroke, TIA
MDedge Rheumatology
Small fiber neuropathy common, vexing in sarcoidosis
MDedge Rheumatology
After Inflectra’s approval, challenges remain for biosimilars
MDedge Rheumatology
A dermatologist’s skin tips for rheumatologists
MDedge Rheumatology
Tofacitinib an alternative treatment for refractory cutaneous dermatomyositis
MDedge Rheumatology
TRACTISS ends rituximab hopes for Sjögren’s syndrome
MDedge Rheumatology
Macitentan falls short to stop digital ulcers in systemic sclerosis
MDedge Rheumatology